Objectives: The aim of this study was to evaluate the characteristics of the renal arterial segment bleeding and assess the outcome of selective renal artery embolization (SRAE). Methods: Data on 35 patients in whom SRAE was performed after percutaneous nephrolithotomy (PCNL) from January 2005 to December 2015 in our institute were retrospectively analyzed. All patients had severe bleeding but failed to respond to conservative therapy. Results: Forty-four SRAEs were performed in 35 patients (36 kidney units) after PCNL. The findings of 44 renal arteriographies before embolization revealed bleeding in 44 renal artery branch segments. Upper artery segment bleeding in 0, upper and anterior segment bleeding in 3, lower and anterior artery segment bleeding in 6, lower artery segment bleeding in 9, posterior artery segment bleeding in 24, and negative finding in 2 patients. Renal arteriography revealed pseudoaneurysms in 20 (45.5%) patients, arteriovenous fistulas in 6 (13.6%) patients, renal artery branch laceration in 16 (36.4%) patients, and negative angiography finding in 2 (4.5%) patients. Acute bleeding in 7 patients (20.0%) and delayed bleeding in 28 patients (80.0%) were observed. The target vascular lesions were successfully treated by embolization in the first time in 28 cases. Six patients underwent 2 sessions and 1 had 3 sessions. New vascular lesions were the most common cause of failure of initial SEAE in our hospital. Abnormal renal function was observed in 5 patients, and they recovered to preoperative or normal level within 3 weeks. Conclusions: The posterior artery segment of the kidney is the most common bleeding site due to the choice of puncture site. Delayed bleeding (>24 h) was the most common type of bleeding. SRAE is an effective and safe method to treat the severe bleeding after PCNL.

1.
Preminger
GM
,
Assimos
DG
,
Lingeman
JE
,
Nakada
SY
,
Pearle
MS
,
Wolf
JS
 Jr
, et al.
Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations
.
J Urol
.
2005
;
173
(
6
):
1991
2000
.
2.
Seitz
C
,
Desai
M
,
Häcker
A
,
Hakenberg
OW
,
Liatsikos
E
,
Nagele
U
, et al.
Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy
.
Eur Urol
.
2012
;
61
(
1
):
146
58
.
3.
Keoghane
SR
,
Cetti
RJ
,
Rogers
AE
,
Walmsley
BH
.
Blood transfusion, embolisation and nephrectomy after percutaneous nephrolithotomy (PCNL)
.
BJU Int
.
2013
;
111
(
4
):
628
32
.
4.
Poulakis
V
,
Ferakis
N
,
Becht
E
,
Deliveliotis
C
,
Duex
M
.
Treatment of renal-vascular injury by transcatheter embolization: immediate and long-term effects on renal function
.
J Endourol
.
2006
;
20
(
6
):
405
9
.
5.
Olvera-Posada
D
,
Tailly
T
,
Alenezi
H
,
Violette
PD
,
Nott
L
,
Denstedt
JD
, et al.
Risk factors for postoperative complications of percutaneous nephrolithotomy at a tertiary referral center
.
J Urol
.
2015
;
194
(
6
):
1646
51
.
6.
El Tayeb
MM
,
Knoedler
JJ
,
Krambeck
AE
,
Paonessa
JE
,
Mellon
MJ
,
Lingeman
JE
.
Vascular complications after percutaneous nephrolithotomy: 10 years of experience
.
Urology
.
2015
;
85
(
4
):
777
81
.
7.
Mao
Q
,
Wang
C
,
Chen
G
,
Tan
F
,
Shen
B
.
Failure of initial superselective renal arterial embolization in the treatment of renal hemorrhage after percutaneous nephrolithotomy: a respective analysis of risk factors
.
Exp Ther Med
.
2019
;
18
(
5
):
4151
6
.
8.
Lin
L
,
Wang
C
,
Pei
R
,
Guan
H
,
Wang
J
,
Yang
M
, et al.
Prophylactic selective arterial embolization for renal angiomyolipomas: efficacy and evaluation of predictive factors of significant shrinkage
.
Int Urol Nephrol
.
2018
;
50
(
10
):
1765
70
.
9.
Srivastava
A
,
Singh
KJ
,
Suri
A
,
Dubey
D
,
Kumar
A
,
Kapoor
R
, et al.
Vascular complications after percutaneous nephrolithotomy: are there any predictive factors?
Urology
.
2005
;
66
(
1
):
38
40
.
10.
Richstone
L
,
Reggio
E
,
Ost
MC
,
Seideman
C
,
Fossett
LK
,
Okeke
Z
, et al.
First prize (tie): hemorrhage following percutaneous renal surgery: characterization of angiographic findings
.
J Endourol
.
2008
;
22
(
6
):
1129
35
.
11.
Kessaris
DN
,
Bellman
GC
,
Pardalidis
NP
,
Smith
AG
.
Management of hemorrhage after percutaneous renal surgery
.
J Urol
.
1995
;
153
(
3 Pt 1
):
604
8
.
12.
Li
L
,
Zhang
Y
,
Chen
Y
,
Zhu
KS
,
Chen
DJ
,
Zeng
XQ
, et al.
A multicentre retrospective study of transcatheter angiographic embolization in the treatment of delayed haemorrhage after percutaneous nephrolithotomy
.
Eur Radiol
.
2015
;
25
(
4
):
1140
7
.
13.
Hong
Y
,
Xu
Q
,
Huang
X
,
Zhu
Z
,
Yang
Q
,
An
L
.
Ultrasound-guided minimally invasive percutaneous nephrolithotomy in the treatment of pediatric patients
.
Medicine
.
2018
;
97
(
13
):
e0174
.
14.
Kokov
D
,
Manka
L
,
Beck
A
,
Winter
A
,
Gerullis
H
,
Karakiewicz
PI
, et al.
Only size matters in stone patients: computed tomography controlled stone-free rates after mini-percutaneous nephrolithotomy
.
Urol Int
.
2019
;
103
(
2
):
166
71
.
15.
Zhang
H
,
Hong
TY
,
Li
G
,
Jiang
N
,
Hu
C
,
Cui
X
, et al.
Comparison of the efficacy of ultra-mini PCNL, flexible ureteroscopy, and shock wave lithotripsy on the treatment of 1–2 cm lower pole renal calculi
.
Urol Int
.
2019
;
102
(
2
):
153
9
.
16.
El-Nahas
AR
,
Shokeir
AA
,
El-Assmy
AM
,
Mohsen
T
,
Shoma
AM
,
Eraky
I
, et al.
Post-percutaneous nephrolithotomy extensive hemorrhage: a study of risk factors
.
J Urol
.
2007
;
177
(
2
):
576
9
.
17.
Zhaohui
H
,
Hanqi
L
,
Xiongbing
L
,
Caixia
Z
,
Shawpong
W
,
Guohua
Z
.
Analysis of repeated renal arteriography after percutaneous nephrolithotomy
.
Urolithiasis
.
2017
;
45
:
495
9
.
18.
Jain
V
,
Ganpule
A
,
Vyas
J
,
Muthu
V
,
Sabnis
RB
,
Rajapurkar
MM
, et al.
Management of non-neoplastic renal hemorrhage by transarterial embolization
.
Urology
.
2009
;
74
(
3
):
522
6
.
19.
Mehran
R
,
Rao
SV
,
Bhatt
DL
,
Gibson
CM
,
Caixeta
A
,
Eikelboom
J
, et al.
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium
.
Circulation
.
2011
;
123
(
23
):
2736
47
.
20.
Wente
MN
,
Veit
JA
,
Bassi
C
,
Dervenis
C
,
Fingerhut
A
,
Gouma
DJ
, et al.
Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition
.
Surgery
.
2007
;
142
(
1
):
20
5
.
21.
Rahbari
NN
,
Garden
OJ
,
Padbury
R
,
Maddern
G
,
Koch
M
,
Hugh
TJ
, et al.
Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS)
.
HPB
.
2011
;
13
(
8
):
528
35
.
22.
Schulman
S
,
Angerås
U
,
Bergqvist
D
,
Eriksson
B
,
Lassen
MR
,
Fisher
W
.
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
.
J Thromb Haemost
.
2010
;
8
(
1
):
202
4
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.